...million) in a series D round. Existing investors Avlar BioVentures; BioOne Capital; Merlin Biosciences; and Lloyds TSB Development Capital...

...Technology 8/12/99 Venture (ND) $6.4 Brian Souter; Ann Gloag 6/14/01 Series C $46.9 Invesco; BankInvest; Lloyds TSB Development Capital...

...will focus on seed and early stage investments in biotechnology and related companies. Investors include Lloyds TSB Development Capital...

...seed and early stage investments in biotechnology and related companies. Investors in the fund include Lloyds TSB Development Capital...

...series C private placement led by Invesco Private Capital. Other investors included BankInvest Asset Management; Lloyds TSB Development Capital...

...drug delivery, medical device, medical services, diagnostics and biotech companies in the U.K. and Europe. Lloyds TSB Development Capital...